InvestorsHub Logo
Followers 55
Posts 13532
Boards Moderated 0
Alias Born 10/12/2006

Re: king oil post# 671

Monday, 12/04/2017 11:07:48 AM

Monday, December 04, 2017 11:07:48 AM

Post# of 3504
I'm not sure why the company hasn't issued a press release on this good news.

On November 29, 2017, Moleculin Biotech, Inc. (the “Company”) was informed that the physician-sponsored Investigational New Drug application made by MD Anderson Cancer Center for a Phase I trial of the Company's licensed drug compound WP1066 in patients with recurrent malignant glioma and brain metastasis from melanoma has been allowed by the U.S. Food and Drug Administration.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News